| |
| |
|
| Insider
Information: |
Jacobsen Michael A |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,009,875 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,500 |
|
|
| Total
Value |
$1,009,875 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sarepta Therapeutics Inc |
SRPT |
VP of Finance and PAO |
2012-08-23 |
7,500 |
2012-08-23 |
0 |
Premium* |
|
|
Omeros Corp |
OMER |
|
2021-02-22 |
14,000 |
2017-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-02-22 |
4 |
AS |
$23.28 |
$188,568 |
D/D |
(8,100) |
14,000 |
0 |
% |
|
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-02-22 |
4 |
OE |
$10.27 |
$83,187 |
D/D |
8,100 |
22,100 |
0 |
- |
|
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-02-19 |
4 |
AS |
$22.64 |
$226,400 |
D/D |
(10,000) |
14,000 |
0 |
% |
|
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-02-19 |
4 |
OE |
$10.27 |
$102,700 |
D/D |
10,000 |
24,000 |
0 |
- |
|
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-02-10 |
4 |
AS |
$22.49 |
$42,731 |
D/D |
(1,900) |
14,000 |
0 |
% |
|
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-02-10 |
4 |
OE |
$10.27 |
$19,513 |
D/D |
1,900 |
15,900 |
0 |
- |
|
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-01-20 |
4 |
OE |
$9.37 |
$93,700 |
D/D |
10,000 |
14,000 |
0 |
- |
|
| OMER |
Omeros Corp |
VP FINANCE AND CAO |
• – – |
2021-01-19 |
4 |
AS |
$19.95 |
$189,525 |
D/D |
(9,500) |
4,000 |
0 |
% |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2018-05-15 |
4 |
OE |
$9.37 |
$166,898 |
D/D |
17,812 |
13,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2018-05-15 |
4 |
AS |
$24.95 |
$319,659 |
D/D |
(12,812) |
8,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2018-05-14 |
4 |
AS |
$22.45 |
$246,501 |
D/D |
(10,980) |
8,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2018-05-14 |
4 |
OE |
$9.37 |
$102,883 |
D/D |
10,980 |
19,480 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2018-01-04 |
4 |
OE |
$9.37 |
$9,370 |
D/D |
1,000 |
8,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2018-01-03 |
4 |
AS |
$22.45 |
$22,899 |
D/D |
(1,020) |
7,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2018-01-03 |
4 |
OE |
$9.37 |
$9,557 |
D/D |
1,020 |
8,520 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-16 |
4 |
AS |
$24.95 |
$299,400 |
D/D |
(12,000) |
7,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-16 |
4 |
OE |
$9.37 |
$131,180 |
D/D |
14,000 |
19,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-15 |
4 |
OE |
$9.37 |
$131,180 |
D/D |
14,000 |
17,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-15 |
4 |
AS |
$22.45 |
$269,400 |
D/D |
(12,000) |
5,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-14 |
4 |
AS |
$19.95 |
$186,533 |
D/D |
(9,350) |
3,500 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-14 |
4 |
OE |
$9.37 |
$120,404 |
D/D |
12,850 |
12,850 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-13 |
4 |
AS |
$19.95 |
$52,868 |
D/D |
(2,650) |
0 |
0 |
- |
|
| OMER |
Omeros Corp |
VP Finance and CAO |
• – – |
2017-06-13 |
4 |
OE |
$9.37 |
$24,831 |
D/D |
2,650 |
2,650 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
VP of Finance and PAO |
• – – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
